Search Results - "Lenhart, G"

The efficacy of a compounded micronutrient supplement on the incidence, duration, and severity of the common cold: A pilot randomized, double-blinded, placebo-controlled trial by Lenhart, James G, Vu, Phuong T, Quackenbush, Kale, LaPorte, Anne, Smith, Jeff

“…Purpose Viral upper respiratory infections are associated with significant health and economic impact. This study sought to determine the efficacy of routine…”
Get full text

Comparison of real-world hypoglycemia rates among Patients Initiating Treatment with Saxagliptin or Glipizide by Johnston, S, Bell, K, Thomson, E, Lenhart, G, Sheehan, J

Get full text

Cost Comparison of First Line Metastatic Renal Cell Carcinoma Treatments Using A Retrospective Claims Dataset by Margolis, J, Princic, N, Doan, J, Lenhart, G, Motzer, R

Get full text

Predictors of Glycemic Control and diabetes-related costs among adult type 2 Diabetes Patients Initiating Therapy with Liraglutide by Durden, E, Lenhart, G, Lopez-Gonzalez, L, Hammer, M, Langer, J

Get full text

Annual Incidence Rates of Herpes Zoster among an Immunocompetent Population In The United States by Johnson, B.H, Gatwood, J, Palmer, L.A, Lenhart, G, Kawai, K, Acosta, C.J

Get full text

PMH19 Combination Utilization Patterns and Treatment Predictors in ADHD in a Commercially Insured Population by Bernauer, M, Farr, A, Haynes, V, Montejano, L.B, Lenhart, G, Pohl, G, Kelsey, D

Get full text

PIN25 Cost-Effectiveness of Efavirenz Versus Rilpivirine in HIV Patients Initiating First-Line Treatment in the United States by Bonafede, M, Juday, T, Lenhart, G, Pan, K, Hebden, T, Correll, T

Get full text

PDB1 Comparing Hypoglycemia Rates for Type 2 Diabetes Patients Treated With Saxagliptin Versus Sulfonylurea: Using Claims Data to Replicate a Clinical Trial by Curkendall, S.M, Zhang, B, Lenhart, G, Thomson, E.E, Bell, K.F, Graham, J.P

Get full text

Clinical-Economic Modeling Analysis Of Human Papillomavirus (Hpv) Co-Testing With Genotyping Versus Primary Hpv Testing For Cervical Cancer Screening by Felix, JC, Lacey, MJ, Miller, JD, Lenhart, GM, Kulkarni, R

Get full text

Visit Entropy Associated with Diabetic Control Outcomes by Dilger, Benjamin T, Gill, Margaret C, Lenhart, Jill G, Garrison, Gregory M

“…Chronic diseases such as type 2 diabetes place a large burden on the health care system and are associated with increased morbidity and mortality. A team-based…”
Get full text

P.3.c.059 Association between antipsychotic treatment and clinical and economic outcomes in schizophrenia and bipolar disorder by Mychaskiw, M, Sanders, K, Alvir, J, Montejano, L, Lenhart, G, O'Gorman, C

Get full text

The effect of fixed combination of fluticasone and salmeterol on asthma drug utilization, asthma drug cost, and episodes of asthma exacerbations by Brixner, D. I., Lenhart, G., Young, D. C., Samuelson, W. M.

“…ABSTRACT Objective: This study evaluated the use and drug costs of inhaled corticosteroids (ICSs), long-acting β2-agonists (LABAs), and fluticasone propionate…”
Get full text

Collaborative Rooming: An Innovative Pilot Project to Overcome Primary Care Challenges by Singh, Gagandeep, Lenhart, Jill G, Helmers, Richard A, Eberle, Michele Renee, Costley, Heather, Roberts, Joel B, Kaplan, Robert S

“…Primary care physicians are overburdened with growing complexities and increasing expectations for primary care visits. To meet expectations, primary care…”
Get full text

Duration of exposure to select DNA-damaging therapy and the risk of secondary myelodysplastic syndrome and acute myeloid leukemia in patients with ovarian or breast cancer in a real-world setting in the United States by Durden, E., Lenhart, G., Meyer, N., Shenolikar, R., Moore, K.N.

Get full text

Direct healthcare costs of hip, vertebral, and non-hip, non-vertebral fractures by Shi, Nianwen, Foley, Kathleen, Lenhart, Gregory, Badamgarav, Enkhe

“…Abstract Limited data exist regarding the cost of non-hip, non-vertebral (NHNV) fractures. Although NHNV fractures may be less expensive than hip and vertebral…”
Get full text

Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Brazil by Lacey, M, Brouillette, M, Libanore, A, Lenhart, G, Tozato, C, Lopes, N, Russell, M

Get full text

PCV59 - Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Brazil by Lacey, M, Brouillette, M, Libanore, A, Lenhart, G, Tozato, C, Lopes, N, Russell, M

Get full text

B55 REASON TO BELIEVE: CLINICAL PH STUDIES: Treatment Patterns After Initial Therapy Among Pulmonary Arterial Hypertension Patients In The United States by Burger, C D, Ozbay, B, Riehle, E, Lenhart, G, White, R J

Get full text

PCV72 - Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Colombia by Lacey, M, Brouillette, M, Karpf, E, Lenhart, G, Barbeau, M, Russell, M

Get full text

Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Colombia by Lacey, M, Brouillette, M, Karpf, E, Lenhart, G, Barbeau, M, Russell, M

“…OBJECTIVES: To analyze the cost-effectiveness of sacubitril/valsartan versus usual care in heart failure with reduced ejection fraction (HFrEF) for patients…”
Get full text